other material
confidence high
sentiment neutral
materiality 0.75
iSpecimen stockholders approve reverse stock split, authorized share increase, and equity line of credit
iSpecimen Inc.
- Reverse stock split approved at ratio from 1:10 to 1:100; Board to set exact ratio.
- Authorized shares increased from 250M to 1B; 1,370,770 voted for.
- Private financings up to >19.99% of shares at sub-minimum price approved for Nasdaq compliance.
- Convertible securities amended to raise conversion price floor from 50% to 80% of lowest VWAP.
- Equity line of credit approved allowing issuance >19.99% of shares at below-minimum price.